Z-0556-2019 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA device recall Z-0556-2019 was initiated by Pfizer Inc. on Oct 2, 2018 and is designated Class II. Reason for recall: The firm received complaints of the wrap coming apart and leaking granular material The recall status is terminated (terminated Aug 28, 2023). Affected quantity: 4956 units.

Recall Details

Product Type
Devices
Report Date
Dec 12, 2018
Initiation Date
Oct 2, 2018
Termination Date
Aug 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4956 units

Product Description

Thermacare HEATWRAPS JOINT PAIN THERAPY, 8 HEATWRAPS; MUSCLE PAIN THERAPY, 3 HEATWRAPS a) UPC 0573301311 b) UPC 0573301311 Product Usage: Provides heat therapy for temporary relief of minor muscular and joint aches and pains associated with overexertion, sprains, and arthritis.

Reason for Recall

The firm received complaints of the wrap coming apart and leaking granular material

Distribution Pattern

US Nationwide Distribution and PR

Code Information

a) UPC 0573301311 Bundled Lot Number 8054HA Carton/Pouch Number T26686 b) UPC 0573301311 Bundled Lot Number 8054HB Carton/Pouch Number T26686

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0556-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.